The Future of Cell and Gene Therapy Manufacturing

Thursday, March 14, 2024

Johnson & Johnson

1000 Rte 202

Raritan, NJ 08869

6:00 PM - 9:00 PM

After having a wonderful event in 2023, many have indicated to have another interesting panel discussion with industry leaders covering the manufacturing of cell and gene therapies. Robert Lechich from GOTIT Quality Services and a past president of the NJ Chapter and with his manufacturing and supply chain background will again facilitate the discussion.

Topics will include examining approaches to reducing manufacturing costs, applying operational excellence techniques, current thoughts of closed systems, applying automation and robotics, information technology applications such as MES and Quality Management Systems and decentralized manufacturing capabilities at point of care facilities.

This year, it will be hosted at the Johnson and Johnson facility in Raritan, NJ with cocktails and dinner.

Panel Moderator

Robert Lechich, Principal Consultant, Global OT-IT Quality Services

Panelists

Dominique DeJaeger, VP Johnson and Johnson

Innovative Medicines - Autologous Therapies Platform

John Tomtishen, SVP and General Manager, Cellares

Ronit Slotky, PhD, Director Cell Therapies Manufacturing, Hackensack University Medical Center

Thomas Heathman, PhD, Chief Commercial Officer, Ori Biotech

David Smith, PhD, VP of Development, BioCentriq

Registration Cost

Registration $70
Sponsorship $200 (includes 1 free registration and recognition on all emails and at the event)